Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 70/100

NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Monday, August 12, 2024 2 min read
Key Takeaway: NeuroOne Medical Technologies Corporation will host a conference call on August 14, 2024, to discuss its financial results for the third quarter of fiscal year 2024 and provide a corporate update. The company specializes in minimally invasive solutions for neurological disorders and aims to improve patient outcomes. The results will cover the period ending June 30, 2024, with additional information about the company's future directions expected during the call.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is focusing on innovative surgical care options for neurological disorders.
  • The upcoming financial results and corporate update indicate transparency and engagement with stakeholders.
  • The company is exploring multiple applications for its technologies, potentially broadening its market.

Full Press Release Details

EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on August 14, 2024, at 4:30 PM Eastern Time to discuss financial results for its third quarter of fiscal year 2024 ended June 30, 2024, and provide a corporate update.
Conference Call and Webcast Information:
Wednesday, August 14, 2024 – 4:30 PM Eastern Time
Toll Free: 877-545-0320
International: 973-528-0002
Participant Access Code: 579769
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 51065
Available through August 28, 2024
Webcast replay available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

Tags

NeuroOne Medical Technologies
2024 Financial Results
Provide Corporate Update
medical technology company

Frequently Asked Questions

When is NeuroOne's upcoming conference call?

NeuroOne's conference call is on August 14, 2024, at 4:30 PM Eastern Time.

What is the purpose of the conference call?

The call will discuss the third-quarter financial results and provide a corporate update.

How can I access the conference call?

You can access it by calling 877-545-0320 or 973-528-0002 and using participant code 579769.

What technologies does NeuroOne focus on?

NeuroOne specializes in minimally invasive solutions for EEG recording and brain stimulation.

What conditions does NeuroOne aim to treat?

They aim to treat epilepsy, Parkinson's disease, chronic pain, and more neurological disorders.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne medical technology neurological disorders Austin financial results
Last updated: Aug 12, 2024